Mario Cazzola1, Maria Gabriella Matera. Show Affiliations » 1. Department of Respiratory Medicine, Cardarelli Hospital, Naples, Italy. mcazzola@qubisoft.it
Abstract
Entities: Gene
Mesh： See more » Adrenergic beta-Agonists/pharmacokineticsAdrenergic beta-Agonists/therapeutic useAirway Obstruction/drug therapyAirway Obstruction/etiologyAlbuterol/analogs & derivativesAlbuterol/pharmacokineticsAlbuterol/therapeutic useBronchodilator Agents/pharmacokineticsBronchodilator Agents/therapeutic useDose-Response Relationship, DrugEthanolamines/pharmacokineticsEthanolamines/therapeutic useFormoterol FumarateHalf-LifeHumansPulmonary Disease, Chronic Obstructive/complicationsPulmonary Disease, Chronic Obstructive/drug therapyPulmonary Disease, Chronic Obstructive/physiopathologySalmeterol Xinafoate
Substances： See more » Adrenergic beta-AgonistsBronchodilator AgentsEthanolaminesSalmeterol XinafoateAlbuterolFormoterol Fumarate
Year: 2003 PMID： 12850121 DOI： 10.1016/S1094-5539(03)00025-7
Source DB: PubMed Journal: Pulm Pharmacol Ther ISSN： 1094-5539 Impact factor: 3.410